Veterinary medicines European public assessment report (EPAR): Nexgard Spectra, afoxolaner,milbemycin oxime, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Fluralaner Intervet, fluralaner, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Innovax-ND-IBD-ILT, avian infectious laryngotracheitis,infectious bursal disease,Marek's disease vaccine (live recombinant),Newcastle disease virus vaccine (inactivated), Status: Authorised

Human medicines European public assessment report (EPAR): Blenrep, belantamab mafodotin, Date of authorisation: 23/07/2025, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Blenrep, belantamab mafodotin, Date of authorisation: 23/07/2025, Revision: 1, Status: Authorised

EU Implementation Guide (IG) on veterinary medicines product data in the Union Product Database - Chapter 6: Examples for submission of legacy data (obsolete)

EU Implementation Guide (IG) on veterinary medicines product data in the Union Product Database - Chapter 4: Process and format for the submission of legacy data on veterinary medicinal products (obsolete)

Veterinary medicines European public assessment report (EPAR): Nobilis Multriva Gm+REOm, avian infectious bursal disease,avian reovirus vaccine (inactivated), Status: Authorised

Veterinary medicines European public assessment report (EPAR): Nobilis Multriva IBm+ND, avian infectious bronchitis virus,Newcastle disease virus vaccine (inactivated), Status: Authorised

Human medicines European public assessment report (EPAR): Pluvicto, lutetium (177Lu) vipivotide tetraxetan, Date of authorisation: 09/12/2022, Revision: 10, Status: Authorised